Molecular lung cancer test identifies patients at high risk of death even after surgery
(Medical Xpress)—One of the toughest issues facing patients who have surgery for very early-stage lung cancer is uncertainty: Despite complete removal of their small lung tumors and no evidence of metastasis, at least one quarter of patients harbor tiny, undetectable clumps of cancer cells that have already spread outside their lungs and will kill them within a few years.
Doctors have no way of telling which cancers will recur, and, as a result, none of these patients receives chemotherapy that might otherwise reduce their chance of dying from the disease.
A new molecular test developed by doctors at the University of California, San Francisco (UCSF) may give doctors the ability to better predict post-operative early-stage lung cancer mortality. This week in the Journal of the American Medical Association (JAMA), the team reports that the test effectively identifies patients with a high likelihood of recurrence even of this very early form of cancer, which is called "T1a node-negative non-squamous, non-small cell lung cancer."
The retrospective study involved analyzing tumors from 1,439 patients in the United States and China who underwent surgery during the last 15 years. These patients belonged to either the Kaiser Permanente Northern California System or had gone to one of three hospitals in mainland China that participate in the China Clinical Trials Consortium.
This video is not supported by your browser at this time.The study showed that the scientists could accurately stratify patients even with the earliest stage of lung cancer into groups at low-, intermediate- or high-risk of death based solely on the activity of 14 different genes found in their tumors. The prognostic information obtained from this molecular analysis of an individual tumor's biology significantly surpassed the information that could be obtained from any conventional prognostic criteria derived either from microscopic examination of the tumors, or from the patients' clinical situations.
"This group of patients with very early disease is expected to increase as screening for lung cancer is more widely implemented," said UCSF thoracic surgeon Michael Mann, MD. A number of hospitals around the country, including UCSF Medical Center, have implemented lung cancer screening programs in the last two years.
More Hope for Lung Cancer Survival
Published guidelines currently recommend chemotherapy for stage I lung cancer patients who are thought to be at very high risk of recurrence. These guidelines, however, provide no criteria to aid in the identification of high-risk patients with T1a node-negative disease.
The UCSF team and their colleagues previously demonstrated that the new assay better identifies high-risk stage I patients than the published criteria. It remained uncertain, however, if high-risk patients could also be identified from among the growing number of patients with the earliest, T1a node-negative cancers. The new report now confirms that the test can successfully identify patients even in this group who have a 50 percent chance of death, and for whom further intervention might also need to be considered.
Lung cancer is currently the most lethal cancer in the world, largely because of its propensity to spread even at very early stages of the disease. As a result, lung cancer is most often diagnosed after it has become incurable. Doctors hope that screening for lung cancer will lead to earlier detection and increase overall survival from the disease, which has not improved after 40 years of research. Identification of patients with these early tumors who are still at high risk of death may further improve the benefit derived from early detection.
Mann is one of several doctors at UCSF who jointly developed the technology upon which the test is based. The test itself was developed by Pinpoint Genomics, a company that was acquired in 2012 by Life Technologies Corp., which is currently making the test available to clinicians throughout the United States. Importantly, the test can be run on standard pathology specimens and does not require any special handling of the tumor tissues.
The article, "Ability of a Prognostic Assay to Identify Patients at High Risk of Mortality Despite Small, Node-Negative Lung Tumors" by Johannes R. Kratz, Stephen K. Van Den Eeden, Jianxing He, David M. Jablons and Michael J. Mann, was published by JAMA on Oct. 23, 2012.
Lung Cancer Statistics
- 226,160 new cases of lung cancer will be diagnosed in 2012
- 160,340 lung cancer deaths expected in 2012
- 6.94% of people born today will be diagnosed with lung cancer during their lifetime
- 1.4 million deaths worldwide caused by lung cancer every year
- $10.3 billion spent in the United States each year on lung cancer treatment
- $281.9 million invested by NCI in lung cancer research in 2010
Journal reference: Journal of the American Medical Association
Provided by University of California, San Francisco
- New lung cancer test predicts survival Jan 26, 2012 | not rated yet | 0
- Will lung cancer recur? A genetic test may provide the answer May 19, 2008 | not rated yet | 0
- Crizotinib reduces tumor size in patients with ALK positive lung cancer Sep 06, 2012 | not rated yet | 0
- CT screening improves lung cancer survival Oct 26, 2006 | not rated yet | 0
- Many lung cancer patients get radiation therapy that may not prolong their lives Feb 13, 2012 | not rated yet | 0
- Separate lives: Neuronal and organismal lifespans decoupled Mar 27, 2013 | 4.9 / 5 (8) | 0
- Sizing things up: The evolutionary neurobiology of scale invariance Feb 28, 2013 | 4.8 / 5 (10) | 14
How can there be villous adenoma in colon, if there are no villi there
6 hours ago As title suggest. Thanks :smile:
How can there be a term called "intestinal metaplasia" of stomach
May 21, 2013 Hello everyone, Ok Stomach's normal epithelium is simple columnar, now in intestinal type of adenocarcinoma of stomach it undergoes "intestinal...
Pressure-volume curve: Elastic Recoil Pressure don't make sense
May 18, 2013 From pressure-volume curve of the lung and chest wall (attached photo), I don't understand why would the elastic recoil pressure of the lung is...
If you became brain-dead, would you want them to pull the plug?
May 17, 2013 I'd want the rest of me to stay alive. Sure it's a lousy way to live but it beats being all-the-way dead. Maybe if I make it 20 years they'll...
MRI bill question
May 15, 2013 Dear PFers, The hospital gave us a $12k bill for one MRI (head with contrast). The people I talked to at the hospital tell me that they do not...
Ratio of Hydrogen of Oxygen in Dessicated Animal Protein
May 13, 2013 As an experiment, for the past few months I've been consuming at least one portion of Jell-O or unflavored Knox gelatin per day. I'm 64, in very...
- More from Physics Forums - Medical Sciences
More news stories
Study leader, Professor John Mathews from the University of Melbourne said this small increase in cancer risk must be weighed against the undoubted benefits from CT scans in diagnosing and monitoring disease.
Cancer 4 hours ago | not rated yet | 0
Cancer survivors are no more likely to stop smoking, cut down on alcohol, or exercise more often than the general population, according to new research published in the British Journal of Cancer today (Wednesday)
Cancer 5 hours ago | not rated yet | 0
Beta-blockers, normally used for high blood pressure, could enhance the effectiveness of chemotherapies in treating neuroblastoma, a type of children's cancer, according to a new study published in the British Jo ...
Cancer 6 hours ago | not rated yet | 0
A Japanese cancer specialist said Wednesday she has started the world's first clinical trial of a powerful, non-surgical, short-term radiation therapy for breast cancer.
Cancer 6 hours ago | 5 / 5 (1) | 0
The gap between life expectancy in patients with a mental illness and the general population has widened since 1985 and efforts to reduce this gap should focus on improving physical health, suggest researchers in a paper ...
Cancer 19 hours ago | not rated yet | 0
42 minutes ago | not rated yet | 0 |
42 minutes ago | not rated yet | 0 |
38 minutes ago | not rated yet | 0 |
Top AIDS scientists were optimistic Wednesday of finding a cure for the disease that has claimed 30 million lives—but said it might not work for all people.
22 minutes ago | not rated yet | 0
It is known that signs of neurological disorders such as Alzheimer's and Huntington's disease can appear years before the disease becomes manifest; these signs take the form of subtle changes in the brain and behavior of ...
36 seconds ago | not rated yet | 0
Widely-used fish oil supplements modestly increase amounts of a hormone that is associated with lower risk of diabetes and heart disease, according to a study accepted for publication in The Endocrine Society's Journal of ...
3 minutes ago | not rated yet | 0